Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Bioadaptives (BDPT) Other Non Operating Income (2019 - 2025)

Bioadaptives' Other Non Operating Income history spans 7 years, with the latest figure at -$71617.0 for Q3 2025.

  • For Q3 2025, Other Non Operating Income fell 184.96% year-over-year to -$71617.0; the TTM value through Sep 2025 reached -$383.0, up 99.9%, while the annual FY2024 figure was -$297071.0, 38.56% up from the prior year.
  • Other Non Operating Income for Q3 2025 was -$71617.0 at Bioadaptives, down from $111658.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $261488.0 in Q3 2023 and bottomed at -$219294.0 in Q2 2021.
  • The 5-year median for Other Non Operating Income is -$74318.5 (2024), against an average of -$50614.4.
  • The largest YoY upside for Other Non Operating Income was 348.7% in 2023 against a maximum downside of 333.18% in 2023.
  • A 5-year view of Other Non Operating Income shows it stood at -$36549.0 in 2021, then surged by 342.32% to $88564.0 in 2022, then crashed by 333.18% to -$206517.0 in 2023, then skyrocketed by 50.57% to -$102083.0 in 2024, then grew by 29.84% to -$71617.0 in 2025.
  • Per Business Quant, the three most recent readings for BDPT's Other Non Operating Income are -$71617.0 (Q3 2025), $111658.0 (Q2 2025), and $61659.0 (Q1 2025).